“It used to be grass roots and now social media has made it incredibly evident and online competitive gaming has BIG BUSINESS and BIG INVESTMENT to back it up. “
Competitive video gaming, also known as electronic sports or e-sports, has experienced a meteoric rise in the past decade or so.
Though e-sports still have a niche audience compared to established professional sports leagues, they’re now a far cry from the days when the only video game tournaments around were Street Fighter matches sponsored by local arcades.
It’s no wonder that gamers across the world take such an interest in their professional counterparts. The video game industry takes in $10.5 billion a year, according to the ESRB. The advent of streaming internet video has bolstered the e-competition industry even more, as it can access worldwide viewership while bypassing the traditional avenue of television coverage. Computer game players are necessarily also regular internet users, and streams have long reach.
Major League Gaming, the largest video game league in the United States, reported 54 million viewer-hours of streaming video watched in 2013, or four times the total number of hours of the NCAA March Madness basketball tournament viewed that year.
Like the Grassroots of e-gaming have exploded so could an early investment opportunity through companies like Chess Supersite Corp (OTCMKTS:CHZP)
These kinds of viewership numbers are enough to give investors like those from MLG the confidence to grant it $69 million in venture capital! The relatively low cost of streaming (viewing it is free as long as you can get online) means big money for everyone involved: the players, the leagues, the broadcasters, the sponsors, and, indeed, the game platform development companies.
Chess Supersite Corp (OTCMKTS:CHZP) is an interactive and educational chess site that will allow members to watch major tournaments with expert commentary, predict moves to win prices, access sophisticated educational material and chat in many languages using instant translation.
“Chess is the sleeping giant of the sports/entertainment world.”
Steve Martin, CEO of M&C Saatchi Sports
It is estimated that an astonishing 650 million people play chess in the World and it’s also estimated that the number of people that play online chess is over 200 million! Chess Supersite Corp (OTCMKTS:CHZP) is building a model to breed world-class competitors while also fostering a network of users. With the emergence of social online competition, CHZP is anticipating multi-million dollar revenue growth just from annual advertising revenue alone.
They will also offer premium membership, events with revenue from event fees, as well as contest fees
And RIGHT NOW The Company Is In Its Own Grass Roots Stage, Set For A Full Launch!
And with new technology emerging that taps directly into the social media market, CHZP could quickly find itself with exponential growth in its viewership. With applications like Twitch that are built specifically for streaming e-gaming, peak viewership could further enhance this market opportunity especially when compared to the “old days” of online chess play.
Game developers and other companies are also on Twitch, streaming footage from tournaments that pit top teams against one another. Riot Games, the company that makes the game League of Legends, holds frequent competitions that attract hundreds of thousands of viewers.
“Now, because games are run as continuous services where people can spend money as they play along, the game companies have bigger incentives to engage and entertain people continuously,” said Peter Warman, chief executive of Newzoo, a research firm that has studied e-sports.
Companies like T-Mobile USA, Coca-Cola, and eve Red Bull are just some of the biggest sponsors of the leading chess matches around the world. Though it may not seem like an “in your face” sport. Matches attract thousands of viewers. Malcolm Pein, British international master and director of the London Chess Classic tournament, states that his matches attracted a total of 160,000 different viewers via a live streaming service!
Senior Advisement By The Industry’s Leading Chess Grand Master!
If you could have any business to start up and be able to have a chance to have one of the leading figureheads of your industry hold your hand and guide you, how valueable would that be?
CHZP has that RIGHT NOW. Garry Kasparov has become a Senior Adviser to the Board of Directors of the Chess Supersite Corporation. Legendary World Chess Champion Grandmaster Garry Kasparov has become the Senior Adviser to the Board of Directors of the Chess Supersite Corporation.
Garry Kasparov is the strongest player in chess history and a member of TIME magazine’s 100 most influential people in the World. He is a prolific author, lecturer, and President of the Kasparov Chess Foundation with offices around the Globe
Garry Kasparov, one of the world’s greatest ambassadors for chess, inspired the Grand Chess Tour. His tireless efforts to popularize the game around the world mirror the goals and ambitions of the Grand Chess Tour. See more at: http://www.grandchesstour.com. Garry Kasparov brings his wisdom, experience, integrity and vision!
Immediate Buying Opportunity for Chess Supersite Corp (CHZP)?
The growth of online competition, the increased viewership of chess and an early phase opportunity that could be a HUGE score for early participants. With CHZP on the verge of launching what could be one of the internet’s foremost destinations for competition, RIGHT NOW may be one of the MOST IMPORTANT times to be paying close attention to this company!
CytoDyn Inc (OTCMKTS:CYDY) Regains Momentum After The Big Announcement
Now that the market seems to be coming back into his elements, it could be time for investors to start looking into penny stocks more closely. These stocks may often be risky, but if one makes the right choice, then the rewards could be enormous. One penny stock that could be put into the watch list at this point in time is that of CytoDyn Inc (OTCMKTS:CYDY).
The late-stage biotechnology company, which is developing the coronavirus medicine leronlimab, announced last week that it had filed a comprehensive application for uplisting on NASDAQ. The company announced that it believes that its application satisfies the myriad listing requirements of the NASDAQ Capital Market.
The Chief Executive Officer and President of the company Nader Pourhassan stated that while it is true that the entire process is expected to take many weeks, CytoDyn is hopeful of success in this matter.
He went on to state that a listing on NASDAQ will not only provide shareholders with more liquidity but also give CytoDyn much bigger access to fresh capital. It is a significant development for the company, and the market participants realized it as well. After the announcement was made, the stock rallied by as much as 50%. Investors could do well to keep an eye on the stock this week.
While the rally following this announcement was a welcome relief for the company, it is important to point out that earlier on in the week, the stock has fallen considerably following a setback. Last Monday, the company announced that the United States Food and Drug Administration handed CytoDyn a refusal to file a letter with regards to the usage of leronlimab to treat HIV.
However, at the same time, investors should be noted that the company did announce that it is confident of furnishing the agency with all the further details that have been demanded. It is one of the penny stocks that have performed remarkably well this year so far, and investors could keep an eye on it.
These 3 Pot Stocks Are Up Big Since May: What’s the Buzz?
Over the course of the past year or so, pot stocks had generally struggled, but during the past month, those stocks have recovered nicely. The stock market suffered a historic fall due to the economic turmoil caused by the coronavirus pandemic. It is believed that investors who are looking for value have descended on the beaten-down pot stocks. On the flip side, these stocks could also have been identified as defensive plays in an uncertain market environment.
That being said, it should be noted that despite the gains recorded by many stocks, most of those stocks are still considerably lower than the all-time highs. In such a situation, it could be worthwhile for investors to take a closer look at some of the strongest and more stable cannabis companies in the industry. Here is a look at three pot stocks that made significant moves in May and could be tracked by investors at this point.
1. HEXO Stock Jumps Ahead of Earnings
HEXO Corp (TSX:HEXO) (NYSE:HEXO) is one of those cannabis companies which have had a particularly tough time over the past year or so. However, the stock has emerged as one of the bigger gainers among pot stocks in recent trading sessions. The Hexo stock has gained as much as 120% over the course of the past month. The company is all set to release its financial results for the fiscal third quarter on Thursday, and hence, it could be a big week for the stock.
The recent surge in the Hexo stock may have come as a major boost to investors, but it should be noted that over the past year, it recorded considerable losses. The beaten-down nature of the stock may have contributed to the stock becoming more attractive for investors. However, the trajectory of the Hexo stock in the near term is going to depend a lot on its third-quarter earnings.
The company had made a loss of $298 million in the previous quarter, and while it is almost certain that it is going to make a loss again, the size of the loss is going to be keenly watched. Additionally, any writedowns are also going to be harmful to the stock. Investors should also keep an eye on sales growth.
2 Organigram gains Momentum on Value Buying
Organigram Holdings (TSX:OGI) (NASDAQ:OGI) is another pot stock that has made significant gains in the past month. Since May 13, the stock has gained as much as 80%. In April, the company announced its fiscal second-quarter results, but it had been a disappointment.
Revenues dropped by 13.7% year on year to hit CA$23.2 million, and losses widened to CA$6.8 million from CA$6.4 million in the prior-year period. However, one significant cause for optimism for Organigram investors is the fact that in the second quarter, cannabis 2.0 products made up as much as 13% of its revenue. That has opened up a whole new opportunity for the company.
Wholesale cannabis revenue made up 24% of the net, and that is again a new source of revenue. The company blamed the lower volumes of flower as well as cannabis oil for the drop in sales. Organigram reported cash and cash equivalents of CA$41.1 million as of February 29. Considering the fact that it has burned CA$25 million in the past six months, investors should not use that the cash balance does not paint a pretty picture.
3 Aphria Recovers Following Solid Earnings
Aphria (TSX:APHA) (NYSE:APHA), on the other hand, managed to perform relatively well in its fiscal third quarter. The net sales rose by as much as 19.7% sequentially to hit CA$144.4 million, and more importantly, the company also managed to record a profit for the third time in four quarters. On top of that, it should be noted that although the Canadian cannabis company spends CA$124.4 million on its operations in the nine months trailing that quarter, it still reported a cash balance of CA$515 million.
The performance seems to have buoyed market participants as well, and the stock has rallied by as much as 75% since the middle of May. One of the most important things that investors are going to be looking into is whether Aphria is going to be able to maintain its profitability.
However, due to the turmoil caused by the coronavirus pandemic, it might prove difficult. That being said, it should be noted that the pandemic is going to have an equally damaging effect across the sector.
ConforMIS Inc (NASDAQ: CFMS): Premium Members Made A Quick 65% Profit In Just 1 week
Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/
JOIN US NOW: For Details Contact us at firstname.lastname@example.org
Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights
Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-
We told our members in facebook private group to buy ConforMIS Inc (NASDAQ: CFMS) yesterday (march 13th) at $1.36. Now look at the price of the stock – its up 65% at $2.25 from our buy price. This is how easy money they made. If you had invested $5,000 in CFMS, it could had been moved up to $8,250. It’s not yet late, join us at email@example.com